Viewing Study NCT03463161


Ignite Creation Date: 2025-12-24 @ 12:47 PM
Ignite Modification Date: 2026-02-01 @ 2:20 PM
Study NCT ID: NCT03463161
Status: TERMINATED
Last Update Posted: 2020-01-27
First Post: 2018-03-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy
Sponsor: University of Chicago
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Squamous Cell Carcinoma View
None Head and Neck Cancer View
Keywords: